newsfilter
← Latest News
Business Wire·

AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases

Includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy manufacturing platform AstraZeneca has entered into a definitive